Considerations for Patient Monitoring Following CAR T and Bispecific Administration: Amir Fathi, MD
Written by
American Journal Managed Care
Published
0
comments
0
min
Amir Fathi, MD, leukemia specialist at Massachusetts General Hospital, discusses the importance of advocacy by both patients and their treatment team and key distinct toxicities that require vigilance.